Craig Gibbs, Asher Biotherapeutics CEO (Asher)

A next-gen IL-2 chal­lenger bags a megaround with RA Cap­i­tal on board to ac­cel­er­ate 'mod­u­lar' drug plat­form

Crack­ing the IL-2 puz­zle box has been a point of con­tention in biotech for years as drug de­vel­op­ers look to beat a slate of se­ri­ous …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland